ISDS Case Map
medicines
The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.
The European Union's demands on India to take on higher intellectual property (IP) standards, if adopted, could spell disaster for the supply of low-cost generic medicines, undermine India's development and set a significant precedent for the future of IPR protection globally, cautioned Dr Carlos M. Correa, an expert on IP and the WTO TRIPS Agreement.
What is slowly emerging is the beginning of a composite oppositition to FTAs in India.
The negotiating texts so far known do indicate that India is resisting many aspects of the EU demands of higher IPRs standards. Analysis by Carlos Correa.
Confronted by a potential pandemic, negotiations for FTAs with
the European Union are taking place in Brussels this week, where more
extensive protections for intellectual property will be discussed.
The EU is more aggressive in its approach to intellectual property in trade agreements than the United States, MEPs learn
The free trade agreement the EU has proposed to Asean deliberately undermines the Doha Declaration on patents and public health.
As negotiations for the South Korea-European Union free trade agreement (Korea-EU FTA) race into their final stages, the inner workings are starting to come to light.
The Peruvian Foreign Trade and Tourism Ministry said Thursday that Peru will not accept raise in medicine prices in the second round of negotiations for a Free Trade Agreement with the European Union..
As the sixth round of negotiations related to the EU-India Free Trade Agreement (FTA) got underway on Tuesday, the police detained a couple of representatives of public interest groups during a peaceful protest in front of the office of the European Commission (EC).
